Clinical Trials Directory

Trials / Completed

CompletedNCT02613117

Research on Oral Tolerability and Product Application/Response of Two Oxalate Products for Dental Patients With Risk of Dentinal Hypersensitivity

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
104 (actual)
Sponsor
Procter and Gamble · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study will assess the oral tolerability and immediate post-treatment safety of topical application for two marketed oxalate products as initial care in dental patients to treat or prevent tooth sensitivity pain that may be attributed to dentinal hypersensitivity.

Conditions

Interventions

TypeNameDescription
DEVICEPotassium Oxalate GelSelf applied
DEVICEPotassium Oxalate LiquidProfessionally Applied
DRUGStannous fluoride pasteSnF2 Paste

Timeline

Start date
2015-11-01
Primary completion
2016-06-01
Completion
2016-06-01
First posted
2015-11-24
Last updated
2020-09-22
Results posted
2020-09-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02613117. Inclusion in this directory is not an endorsement.